Intuitive Surgical, Inc. $ISRG Stock Purchased by Investment Partners LTD.

Posted by Geri Gentry on Nov 1st, 2026

Investment Partners LTD. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 105.9% during the third quarter, Holdings Channel.com reports. The institutional investor owned 2,854 shares of the medical equipment provider’s stock after acquiring an additional 1,468 shares during the quarter. Investment Partners LTD.’s holdings in Intuitive Surgical were worth $1,161,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the second quarter worth $1,335,753,000. Amundi grew its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after buying an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares in the last quarter. Finally, Janus Henderson Group PLC increased its holdings in Intuitive Surgical by 3.7% in the 1st quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock worth $757,489,000 after buying an additional 58,587 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on ISRG shares. TD Cowen reiterated a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research report on Monday, October 19th. Leerink Partners set a $503.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 21st. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. Truist Financial decreased their price target on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. Finally, BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Check Out Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Trading Down 3.7%

NASDAQ ISRG opened at $432.01 on Friday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a market capitalization of $149.75 billion, a PE ratio of 52.24, a price-to-earnings-growth ratio of 2.98 and a beta of 1.46. The business’s 50-day moving average price is $401.54 and its 200 day moving average price is $434.05.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same period last year, the business posted $2.40 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the transaction, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This represents a 79.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the completion of the transaction, the director directly owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. The trade was a 1.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 38,778 shares of company stock worth $16,814,967 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.